Effective measures for the secondary prevention of subependymal<unk>  cell astrocytoma include brain imaging, preferably magnetic resonance imaging with and without contrast, which should be performed every 1 to 3 years until the age of 25 years in every patient with tuberous sclerosis.
Subependymal giant cell astrocytoma secondary prevention
Ependymoma secondary prevention
Subependymal giant cell astrocytoma medical therapy
Oligoastrocytoma secondary prevention
Neurofibroma medical therapy
Brain Stem Gliomas medical therapy
Medulloblastoma medical therapy
Meningioma medical therapy